Tambua Health

Tambua Health offers NoDraw, an enterprise AI agent that derives blood marker estimates from smartphone-based optical scans of the eye and skin to support blood diagnostics and companion diagnostics workflows. The platform provides guided capture, AI inference of blood markers, and workflow routing for clinical dashboards and review/escalation paths.

NoDraw captures optical signals from the eye and skin via a guided capture studio with real-time quality gates, infers core blood markers using AI models, and outputs confidence-scored estimates for clinical workflows. Outputs feed review queues, escalation pathways, and clinical dashboards. It covers hemoglobin, RBC count, WBC count, hematocrit, platelet count, MCV, and MCH for monitoring across anemia, metabolic, liver, and cardiorenal pathways. The platform includes enterprise AI agent capabilities for bloodless diagnostics and companion diagnostics workflow orchestration with program and pathway integration.

Who it’s for: Healthcare providers and enterprises implementing diagnostic and companion diagnostic workflows requiring non-invasive blood marker monitoring and AI-assisted clinical workflow orchestration.

Mentions enterprise pilot programs, technical discovery for biomarker scope and pilot success metrics, and enterprise AI agent capabilities indicate early commercial traction and ongoing customer engagements.